SEC 13F Intelligence

Boxer Capital, LLC / ORIC

Boxer Capital, LLC’s Oric Pharmaceuticals Inc Position

Does Boxer Capital, LLC own Oric Pharmaceuticals Inc (ORIC)? Not currently — the last reported position was 1.73M shares worth $18M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$18M
Q3 2024
Shares
1.73M
% of Portfolio
+0.87%
Quarters Held
16
position exited

Position History ORIC

Reported value by quarter
Q4 ’20: $7MQ4 ’20Q1 ’21: $5MQ2 ’21: $4MQ2 ’21Q3 ’21: $4MQ4 ’21: $3MQ4 ’21Q1 ’22: $6MQ2 ’22: $5MQ2 ’22Q3 ’22: $3MQ4 ’22: $7MQ4 ’22Q1 ’23: $6,008Q2 ’23: $13,445Q2 ’23Q3 ’23: $10MQ4 ’23: $16MQ4 ’23Q1 ’24: $24MQ2 ’24: $12MQ2 ’24Q3 ’24: $18Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20241.73M$18M+0.87%
Q2 20241.73M$12M+0.65%
Q1 20241.73M$24M+1.18%
Q4 20231.73M$16M+0.79%
Q3 20231.73M$10M+0.56%
Q2 20231.73M$13,445+0.62%
Q1 20231.05M$6,008+0.30%
Q4 20221.05M$7M+0.39%
Q3 20221.05M$3M+0.19%
Q2 20221.05M$5M+0.30%
Q1 20221.05M$6M+0.29%
Q4 2021200.0K$3M+0.11%
Q3 2021200.0K$4M+0.15%
Q2 2021200.0K$4M+0.12%
Q1 2021200.0K$5M+0.17%
Q4 2020200.0K$7M+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of ORIC.